Summary

Surgical Site Infection Control Market Summary

The global surgical site infection control market size was estimated at USD 7.57 billion in 2024 and is expected to reach USD 16.22 billion by 2033, growing at a CAGR of 8.73% from 2025 to 2033. This growth is attributed to the growing number of surgical procedures being conducted globally, driven by the rising incidence of chronic illnesses such as cancer, cardiovascular diseases, and diabetes.

Moreover, heightened awareness among healthcare professionals and patients about the risks and complications of surgical infections has intensified the emphasis on patient safety and quality care. Innovations in technology, such as antimicrobial sutures, specialized wound dressings, and sterilization tools, are also enhancing the effectiveness of infection control strategies.

Global Surgical Site Infection Control Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global surgical site infection (SSI) control market report based on product, procedure, type of infection, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Manual Reprocessors Solution
• Disinfectants
o Hand Disinfectants
o Skin Disinfectants
• Surgical Scrubs
• Hair Clippers
• Surgical Drapes
• Surgical Irrigation
• Skin Preparation Solution
• Medical Nonwovens
• Surgical Gloves
• Others
• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Cataract Surgery
• Cesarean Section
• Dental Restoration
• Gastric Bypass
• Others
• Type of Infection Outlook (Revenue, USD Million, 2021 - 2033)
• Superficial Incisional SSI
• Deep Incisional SSI
• Organ SSI
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Segment Definitions
1.2.1 Product
1.2.2 Procedure
1.2.3 Type of Infection
1.2.4 End Use
1.3 Research Methodology
1.3.1 Commodity flow analysis
1.3.2 Information procurement
1.3.2.1 Purchased database
1.3.2.2 GVR’s internal database
1.3.2.3 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 List of Secondary Sources
1.7 List of Abbreviations
1.8 Objectives
Chapter 2. Executive Summary
2.1 Market Snapshot
2.2 Market Segmentation
2.4 Competitive Landscape
Chapter 3. Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Industry Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 PESTLE Analysis
Chapter 4. Surgical Site Infection Control Market: Product Estimates & Trend Analysis
4.1 Surgical Site Infection Control Market: Product Segment Dashboard
4.2 Product Movement & Market Share Analysis, 2024 & 2033
4.3 Global Surgical Site Infection Control Market Size Estimates & Forecast, by Product
4.3.1 Manual Reprocessors Solution
4.3.1.1 Manual Reprocessors Solution Market, 2021 - 2033 (USD Million)
4.3.2 Disinfectants
4.3.2.1 Disinfectants Market, 2021 - 2033 (USD Million)
4.3.2.2 Hand Disinfectants Market, 2021 - 2033 (USD Million)
4.3.2.2.1 Hand Disinfectants Market, 2021 - 2033 (USD Million)
4.3.2.3 Skin Disinfectants Market, 2021 - 2033 (USD Million)
4.3.2.3.1 Skin Disinfectants Market, 2021 - 2033 (USD Million)
4.3.3 Surgical Scrubs
4.3.3.1 Surgical Scrubs Market, 2021 - 2033 (USD Million)
4.3.4 Hair Clippers
4.3.4.1 Hair Clippers Market, 2021 - 2033 (USD Million)
4.3.5 Surgical Drapes
4.3.5.1 Surgical Drapes Market, 2021 - 2033 (USD Million)
4.3.6 Surgical Irrigation
4.3.6.1 Surgical Irrigation Market, 2021 - 2033 (USD Million)
4.3.7 Skin Preparation Solution
4.3.7.1 Skin Preparation Solution Market, 2021 - 2033 (USD Million)
4.3.8 Medical Nonwovens
4.3.8.1 Medical Nonwovens Market, 2021 - 2033 (USD Million)
4.3.9 Surgical Gloves
4.3.9.1 Surgical Gloves Market, 2021 - 2033 (USD Million)
4.3.10 Others
4.3.10.1 Others Market, 2021 - 2033 (USD Million)
Chapter 5. Surgical Site Infection Control Market: Procedure Estimates & Trend Analysis
5.1 Surgical Site Infection Control Market: Procedure Segment Dashboard
5.2 Procedure Movement & Market Share Analysis, 2024 & 2033
5.3 Global Surgical Site Infection Control Market Size Estimates & Forecast, by Procedure
5.3.1 Cataract Surgery
5.3.1.1 Cataract Surgery Market, 2021 - 2033 (USD Million)
5.3.2 Cesarean Section
5.3.2.1 Cesarean Section Market, 2021 - 2033 (USD Million)
5.3.3 Dental Restoration
5.3.3.1 Dental Restoration Market, 2021 - 2033 (USD Million)
5.3.4 Gastric Bypass
5.3.4.1 Gastric Bypass Market, 2021 - 2033 (USD Million)
5.3.5 Others
5.3.5.1 Others Market, 2021 - 2033 (USD Million)
Chapter 6. Surgical Site Infection Control Market: Type of Infection Estimates & Trend Analysis
6.1 Surgical Site Infection Control Market: Type of Infection Segment Dashboard
6.2 Type of Infection Movement & Market Share Analysis, 2024 & 2033
6.3 Global Surgical Site Infection Control Market Size Estimates & Forecast, by Type of Infection
6.3.1 Superficial Incisional SSI
6.3.1.1 Superficial Incisional SSI Market, 2021 - 2033 (USD Million)
6.3.2 Deep Incisional SSI
6.3.2.1 Deep Incisional SSI Market, 2021 - 2033 (USD Million)
6.3.3 Organ SSI
6.3.3.1 Organ or Space SSI Market, 2021 - 2033 (USD Million)
Chapter 7. Surgical Site Infection Control Market: End Use Estimates & Trend Analysis
7.1 Surgical Site Infection Control Market: End Use Segment Dashboard
7.2 End Use Movement & Market Share Analysis, 2024 & 2033
7.3 Global Surgical Site Infection Control Market Size Estimates & Forecast, by End Use
7.3.1 Hospitals
7.3.1.1 Hospitals Market, 2021 - 2033 (USD Million)
7.3.2 Ambulatory Surgical Centers
7.3.2.1 Ambulatory Surgical Centers Market, 2021 - 2033 (USD Million)
Chapter 8. Surgical Site Infection Control Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework
8.4.1.3. Competitive scenario
8.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive scenario
8.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive scenario
8.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework
8.5.1.3. Competitive scenario
8.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive scenario
8.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive scenario
8.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive scenario
8.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive scenario
8.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework
8.6.1.3. Competitive scenario
8.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework
8.7.1.3. Competitive scenario
8.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework
8.8.1.3. Competitive scenario
8.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Key company market position analysis, 2024
9.4. List of Companies
9.4.1. Getinge Group
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Steris Healthcare
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. 3M
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. BD
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. BELIMED INC.
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. POLYMERFILMS
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. ANSELL LTD.
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Olympus Corporation
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Systec GmbH & Co. KG
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Ecolab Inc.
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. MMM Group
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. Pal International
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
9.4.13. Miele Group
9.4.13.1. Company overview
9.4.13.2. Financial performance
9.4.13.3. Product benchmarking
9.4.13.4. Strategic initiatives
9.4.14. Belimed AG
9.4.14.1. Company overview
9.4.14.2. Financial performance
9.4.14.3. Product benchmarking
9.4.14.4. Strategic initiatives